Uncommon Cents Investing LLC Has $2.55 Million Stock Position in CVS Health Co. (NYSE:CVS)

Uncommon Cents Investing LLC decreased its stake in CVS Health Co. (NYSE:CVSGet Rating) by 0.5% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 27,510 shares of the pharmacy operator’s stock after selling 145 shares during the quarter. Uncommon Cents Investing LLC’s holdings in CVS Health were worth $2,549,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Macroview Investment Management LLC lifted its stake in CVS Health by 128.3% in the 1st quarter. Macroview Investment Management LLC now owns 242 shares of the pharmacy operator’s stock worth $25,000 after acquiring an additional 136 shares in the last quarter. Claremont Financial Group Inc. bought a new position in shares of CVS Health in the 4th quarter valued at approximately $26,000. Stuart Chaussee & Associates Inc. raised its stake in shares of CVS Health by 123.0% in the 1st quarter. Stuart Chaussee & Associates Inc. now owns 310 shares of the pharmacy operator’s stock valued at $31,000 after acquiring an additional 171 shares in the last quarter. Rise Advisors LLC acquired a new stake in CVS Health in the 4th quarter valued at approximately $41,000. Finally, Carl Stuart Investment Advisor Inc. acquired a new stake in CVS Health in the 1st quarter valued at approximately $41,000. Institutional investors and hedge funds own 77.64% of the company’s stock.

Insider Transactions at CVS Health

In other news, EVP Alan Lotvin sold 22,541 shares of the company’s stock in a transaction dated Thursday, August 4th. The stock was sold at an average price of $104.00, for a total transaction of $2,344,264.00. Following the completion of the transaction, the executive vice president now directly owns 109,183 shares of the company’s stock, valued at $11,355,032. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, EVP Alan Lotvin sold 22,541 shares of the company’s stock in a transaction dated Thursday, August 4th. The stock was sold at an average price of $104.00, for a total transaction of $2,344,264.00. Following the sale, the executive vice president now owns 109,183 shares in the company, valued at $11,355,032. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Thomas M. Moriarty sold 138,654 shares of the company’s stock in a transaction dated Tuesday, June 28th. The stock was sold at an average price of $95.00, for a total value of $13,172,130.00. Following the sale, the executive vice president now owns 626,273 shares in the company, valued at approximately $59,495,935. The disclosure for this sale can be found here. 0.69% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

CVS has been the topic of a number of research analyst reports. Tigress Financial raised their target price on CVS Health from $125.00 to $130.00 in a report on Wednesday, August 17th. UBS Group raised their target price on CVS Health from $118.00 to $127.00 and gave the company a “buy” rating in a report on Thursday, August 4th. Mizuho raised their target price on CVS Health from $115.00 to $120.00 and gave the company a “buy” rating in a report on Monday, August 15th. Loop Capital began coverage on CVS Health in a report on Thursday, June 16th. They set a “buy” rating and a $120.00 price objective on the stock. Finally, Evercore ISI lifted their price objective on CVS Health from $120.00 to $125.00 and gave the stock an “outperform” rating in a report on Wednesday, September 7th. Four analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $117.59.

CVS Health Trading Down 2.0 %

Shares of CVS stock traded down $1.99 on Friday, reaching $97.84. 166,419 shares of the stock were exchanged, compared to its average volume of 4,398,985. The stock has a market cap of $128.45 billion, a PE ratio of 15.91, a P/E/G ratio of 1.52 and a beta of 0.73. CVS Health Co. has a one year low of $81.78 and a one year high of $111.25. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.91 and a quick ratio of 0.65. The stock has a 50 day moving average price of $100.14 and a 200 day moving average price of $99.28.

CVS Health (NYSE:CVSGet Rating) last announced its quarterly earnings data on Wednesday, August 3rd. The pharmacy operator reported $2.40 EPS for the quarter, topping analysts’ consensus estimates of $2.16 by $0.24. CVS Health had a return on equity of 15.19% and a net margin of 2.65%. The business had revenue of $80.64 billion during the quarter, compared to analysts’ expectations of $76.38 billion. During the same period in the previous year, the firm earned $2.42 earnings per share. The firm’s quarterly revenue was up 11.0% compared to the same quarter last year. Equities research analysts forecast that CVS Health Co. will post 8.53 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 1st. Stockholders of record on Friday, October 21st will be given a dividend of $0.55 per share. The ex-dividend date is Thursday, October 20th. This represents a $2.20 annualized dividend and a dividend yield of 2.25%. CVS Health’s dividend payout ratio is currently 35.77%.

CVS Health Profile

(Get Rating)

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.

Recommended Stories

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.